Artivion, Inc. Common Stock (NY:AORT)

22.73 +0.42 (+1.88%)

Delayed Quote Updated: 11:25 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Artivion, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >

A Congress Member Bought Up To $200K In Artivion Stock: Here's What You Need To Know ↗

November 21, 2023

Via Benzinga

Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket ↗

November 21, 2023

Shares of Symbotic Inc. (NASDAQ: SYM) surged in pre-market trading after the company reported better-than-expected fourth-quarter sales results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 21, 2023

It's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!

Via InvestorPlace

Earnings Preview: Artivion ↗

August 02, 2023

Via Benzinga

Artivion: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

Earnings Scheduled For February 16, 2023 ↗

February 16, 2023

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...

Via Benzinga

This Analyst Says Artivion's Sell Off Seems Overdone After Trial Halt ↗

September 26, 2022

Via Benzinga

4 Analysts Have This to Say About Artivion ↗

September 26, 2022

Artivion (NYSE:AORT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Under Armour To Rally Over 13%? Here Are 5 Other Price Target Changes For Friday ↗

November 04, 2022

Via Benzinga

This Senator Just Bought Up To $100K In Artivion Stock ↗

October 18, 2022

The Office of Senator Tina Smith reported a purchase of Artivion (NYSE:AORT) stock on October 17, 2022. According to the October filing, the transaction was made on October 17, 2022.

Via Benzinga

Oppenheimer Maintains Outperform Rating for Artivion: Here's What You Need To Know ↗

September 26, 2022

Oppenheimer has decided to maintain its Outperform rating of Artivion (NYSE:AORT) and lower its price target from $35.00 to $25.00. Shares of Artivion are trading up 1.43% over the last 24 hours, at...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 23, 2022

Gainers

Via Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today ↗

September 23, 2022

Artivion (NYSE:AORT) has outperformed the market over the past 20 years by 1.64% on an annualized basis producing an average annual return of 9.19%. Currently, Artivion has a market capitalization of...

Via Benzinga

Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance ↗

September 23, 2022

Via Benzinga

Earnings Scheduled For February 17, 2022 ↗

February 17, 2022

Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.

Via Benzinga

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday ↗

September 26, 2022

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.

Via Benzinga

Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗

September 23, 2022

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day...

Via Benzinga

US Stocks Open Lower; Dow Tumbles 400 Points ↗

September 23, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 400 points on Friday.

Via Benzinga

Artivion: Q2 Earnings Insights ↗

August 04, 2022

Artivion (NYSE:AORT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Artivion beat estimated earnings by...

Via Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗

July 27, 2022

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

April 07, 2022

On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high...

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

March 03, 2022

On Thursday, 95 companies set new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to break to a new 52-week high...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 ↗

March 03, 2022

Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,...

Via Benzinga

Recap: Artivion Q4 Earnings ↗

February 17, 2022

Artivion (NYSE:AORT) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Artivion missed estimated earnings...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.